Research work · 2017
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael James Overman, Ray McDermott, Joseph L. Leach
The Lancet Oncology